CLB logo

Core Laboratories NV (CLB) Accounts Receivable

Annual Accounts Receivable

$111.76 M
+$2.41 M+2.20%

December 31, 2024


Summary


Performance

CLB Accounts Receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCLBbalance sheetmetrics:

Quarterly Accounts Receivable

$111.76 M
-$5.83 M-4.96%

December 31, 2024


Summary


Performance

CLB Quarterly Accounts Receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCLBbalance sheetmetrics:

Accounts Receivable Formula

Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales

CLB Accounts Receivable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+2.2%0.0%
3 y3 years+15.4%+13.0%
5 y5 years-15.1%+19.9%

CLB Accounts Receivable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+15.4%-5.0%+15.4%
5 y5-year-15.1%+34.3%-15.1%+34.3%
alltimeall time-44.5%+34.3%-46.6%+34.3%

Core Laboratories NV Accounts Receivable History

DateAnnualQuarterly
Dec 2024
$111.76 M(+2.2%)
$111.76 M(-5.0%)
Sep 2024
-
$117.59 M(+1.7%)
Jun 2024
-
$115.64 M(+0.5%)
Mar 2024
-
$115.09 M(+5.2%)
Dec 2023
$109.35 M(+2.3%)
$109.35 M(+5.1%)
Sep 2023
-
$104.05 M(-2.6%)
Jun 2023
-
$106.82 M(-3.5%)
Mar 2023
-
$110.70 M(+3.5%)
Dec 2022
$106.91 M(+10.4%)
$106.91 M(+6.7%)
Sep 2022
-
$100.19 M(+1.0%)
Jun 2022
-
$99.18 M(+0.3%)
Mar 2022
-
$98.90 M(+2.1%)
Dec 2021
$96.83 M(+16.4%)
$96.83 M(+1.6%)
Sep 2021
-
$95.30 M(+2.2%)
Jun 2021
-
$93.22 M(+7.7%)
Mar 2021
-
$86.57 M(+4.1%)
Dec 2020
$83.19 M(-36.8%)
$83.19 M(-2.5%)
Sep 2020
-
$85.37 M(-15.9%)
Jun 2020
-
$101.46 M(-20.0%)
Mar 2020
-
$126.87 M(-3.6%)
Dec 2019
$131.58 M(+1.9%)
$131.58 M(-4.2%)
Sep 2019
-
$137.35 M(+1.8%)
Jun 2019
-
$134.90 M(+1.5%)
Mar 2019
-
$132.86 M(+2.9%)
Dec 2018
$129.16 M(-3.0%)
$129.16 M(-9.9%)
Sep 2018
-
$143.32 M(+5.3%)
Jun 2018
-
$136.15 M(-1.1%)
Mar 2018
-
$137.66 M(+3.4%)
Dec 2017
$133.10 M(+16.4%)
$133.10 M(+2.7%)
Sep 2017
-
$129.66 M(+0.5%)
Jun 2017
-
$128.98 M(+5.9%)
Mar 2017
-
$121.81 M(+6.5%)
Dec 2016
$114.33 M(-21.5%)
$114.33 M(+5.4%)
Sep 2016
-
$108.52 M(-2.9%)
Jun 2016
-
$111.75 M(-8.8%)
Mar 2016
-
$122.50 M(-15.9%)
Dec 2015
$145.69 M(-26.1%)
$145.69 M(-4.4%)
Sep 2015
-
$152.45 M(-1.7%)
Jun 2015
-
$155.11 M(-2.4%)
Mar 2015
-
$158.86 M(-19.4%)
Dec 2014
$197.16 M(-2.1%)
$197.16 M(-2.3%)
Sep 2014
-
$201.77 M(+0.4%)
Jun 2014
-
$200.99 M(-3.9%)
Mar 2014
-
$209.23 M(+3.9%)
Dec 2013
$201.32 M(+9.0%)
$201.32 M(-1.9%)
Sep 2013
-
$205.12 M(+7.5%)
Jun 2013
-
$190.87 M(-4.6%)
Mar 2013
-
$200.14 M(+8.3%)
DateAnnualQuarterly
Dec 2012
$184.77 M(+8.2%)
$184.77 M(+2.4%)
Sep 2012
-
$180.40 M(+5.7%)
Jun 2012
-
$170.71 M(-0.6%)
Mar 2012
-
$171.66 M(+0.5%)
Dec 2011
$170.81 M(+10.4%)
$170.81 M(+8.4%)
Sep 2011
-
$157.59 M(-1.6%)
Jun 2011
-
$160.21 M(+1.2%)
Mar 2011
-
$158.31 M(+2.3%)
Dec 2010
$154.73 M(+15.7%)
$154.73 M(+9.6%)
Sep 2010
-
$141.11 M(+2.6%)
Jun 2010
-
$137.56 M(+5.0%)
Mar 2010
-
$130.99 M(-2.1%)
Dec 2009
$133.76 M(-7.3%)
$133.76 M(+13.4%)
Sep 2009
-
$117.98 M(-4.8%)
Jun 2009
-
$123.95 M(-5.8%)
Mar 2009
-
$131.56 M(-8.8%)
Dec 2008
$144.29 M(+5.1%)
$144.29 M(-4.0%)
Sep 2008
-
$150.26 M(+0.7%)
Jun 2008
-
$149.14 M(+1.6%)
Mar 2008
-
$146.74 M(+6.9%)
Dec 2007
$137.23 M(+22.5%)
$137.23 M(-1.2%)
Sep 2007
-
$138.88 M(+7.9%)
Jun 2007
-
$128.68 M(+4.8%)
Mar 2007
-
$122.84 M(+9.6%)
Dec 2006
$112.06 M(+13.0%)
$112.06 M(+0.9%)
Sep 2006
-
$111.06 M(+4.3%)
Jun 2006
-
$106.52 M(-2.2%)
Mar 2006
-
$108.88 M(+9.8%)
Dec 2005
$99.13 M(+3.9%)
$99.13 M(+1.5%)
Sep 2005
-
$97.66 M(+1.0%)
Jun 2005
-
$96.73 M(-1.5%)
Mar 2005
-
$98.16 M(+2.8%)
Dec 2004
$95.45 M(+7.0%)
$95.45 M(+2.1%)
Sep 2004
-
$93.46 M(+3.0%)
Jun 2004
-
$90.74 M(+1.4%)
Mar 2004
-
$89.53 M(+0.4%)
Dec 2003
$89.20 M(-11.3%)
$89.20 M(-14.8%)
Sep 2003
-
$104.64 M(-1.1%)
Jun 2003
-
$105.82 M(+7.0%)
Mar 2003
-
$98.90 M(-1.7%)
Dec 2002
$100.60 M(-4.1%)
$100.60 M(+9.1%)
Sep 2002
-
$92.19 M(+4.7%)
Jun 2002
-
$88.03 M(-8.2%)
Mar 2002
-
$95.91 M(-8.6%)
Dec 2001
$104.93 M(-7.3%)
$104.93 M(-7.6%)
Sep 2001
-
$113.51 M(+5.0%)
Jun 2001
-
$108.08 M(+2.6%)
Mar 2001
-
$105.34 M(-7.0%)
Dec 2000
$113.21 M
$113.21 M

FAQ

  • What is Core Laboratories NV annual accounts receivable?
  • What is the all time high annual accounts receivable for Core Laboratories NV?
  • What is Core Laboratories NV annual accounts receivable year-on-year change?
  • What is Core Laboratories NV quarterly accounts receivable?
  • What is the all time high quarterly accounts receivable for Core Laboratories NV?
  • What is Core Laboratories NV quarterly accounts receivable year-on-year change?

What is Core Laboratories NV annual accounts receivable?

The current annual accounts receivable of CLB is $111.76 M

What is the all time high annual accounts receivable for Core Laboratories NV?

Core Laboratories NV all-time high annual accounts receivable is $201.32 M

What is Core Laboratories NV annual accounts receivable year-on-year change?

Over the past year, CLB annual accounts receivable has changed by +$2.41 M (+2.20%)

What is Core Laboratories NV quarterly accounts receivable?

The current quarterly accounts receivable of CLB is $111.76 M

What is the all time high quarterly accounts receivable for Core Laboratories NV?

Core Laboratories NV all-time high quarterly accounts receivable is $209.23 M

What is Core Laboratories NV quarterly accounts receivable year-on-year change?

Over the past year, CLB quarterly accounts receivable has changed by $0.00 (0.00%)